TWiV 1034: Clinical update with Dr. Daniel Griffin
Episode description
In his weekly clinical update, Dr. Griffin discusses the immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate, association between nose picking and SARS-CoV-2 incidence, a cohort study in hospital health care workers; effect of COVID-19 vaccination and booster on maternal-fetal outcomes, dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA, does monoclonal antibody treatment for COVID-19 impact short and long- term outcomes in a large generalizable population, persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and chronic inflammation, core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a influenza A vaccine candidate (The Lancet)
- Association between nose picking and SARS-CoV-2 incidence (PLOSONE)
- Effect of COVID-19 vaccination and booster on maternal-fetal outcomes (Lancet Digital Health)
- Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status (The Lancet)
- Does monoclonal antibody treatment for COVID-19 impact short and long-term outcomes (BMJ)
- Persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and inflammation (Angiogenesis)
- Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts (STM)
- Contribute to our Floating Doctors fundraiser at PWB
- Letters read on TWiV 1034
- Dr. Griffin’s COVID treatment summary (pdf)
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to [email protected]